Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001061557 | SCV001226304 | uncertain significance | Cohen syndrome | 2022-09-07 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 588 of the VPS13B protein (p.Ser588Gly). This variant is present in population databases (rs759332797, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 856158). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV001061557 | SCV001806349 | uncertain significance | Cohen syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001061557 | SCV002079479 | uncertain significance | Cohen syndrome | 2020-03-04 | no assertion criteria provided | clinical testing |